Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC 332488): A new triepoxide cytostatic agent
- 1 March 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (3) , 301-305
- https://doi.org/10.1016/0277-5379(85)90129-4
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Phase-I study of ?-1,3,5-Triglycidyl-s-triazinetrione (NSC 296934)Cancer Chemotherapy and Pharmacology, 1983